Non-Invasive Hemodynamic And Echocardiographic Changes Following Vericiguat Initiation In Heart Failure With Reduced Ejection Fraction: A Prospective Registry Study.
Vericiguat reduces cardiovascular death and heart failure (HF) hospitalization in high-risk patients with HF and reduced ejection fraction (HFrEF), but its non-invasive haemodynamic and remodelling effects in real-world practice remain incompletely characterized. We aimed to evaluate changes in non-invasive hemodynamic...